Based on the comparison of relative reduced levels between CD31-positive vessels with VEGFR-2-positive vessels in each tumor, VEGFR-2 expression was more reduced in tumor blood vessels compared to CD31 expression after VEGF blockade, mABL001 treatment, or the combination treatment (Figure 3B,C). Here, KDR is linked to neoplasm.